| 6.4 |
25.8 |
GO:0090238 |
positive regulation of arachidonic acid secretion(GO:0090238) |
| 6.1 |
18.4 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 6.1 |
18.4 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 5.4 |
16.2 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 5.3 |
15.8 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 5.2 |
15.5 |
GO:0061075 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 5.1 |
30.4 |
GO:0097646 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 4.9 |
14.6 |
GO:0035934 |
corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 4.7 |
23.4 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 4.4 |
13.1 |
GO:0002030 |
inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
| 4.3 |
12.9 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 4.1 |
20.7 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 4.0 |
4.0 |
GO:0035793 |
cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 3.8 |
7.6 |
GO:0038042 |
dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
| 3.7 |
11.1 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 3.6 |
3.6 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 3.6 |
14.3 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 3.5 |
7.0 |
GO:0086017 |
Purkinje myocyte action potential(GO:0086017) membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 3.5 |
17.4 |
GO:0034372 |
very-low-density lipoprotein particle remodeling(GO:0034372) |
| 3.4 |
17.0 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 3.4 |
16.9 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 3.3 |
9.9 |
GO:0072378 |
blood coagulation, fibrin clot formation(GO:0072378) |
| 3.3 |
9.9 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 3.3 |
9.8 |
GO:0071336 |
regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 3.3 |
9.8 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 3.1 |
12.5 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 3.1 |
6.1 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 3.0 |
12.2 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 3.0 |
12.1 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) |
| 3.0 |
9.0 |
GO:0042323 |
negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 3.0 |
18.1 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 3.0 |
9.0 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 2.9 |
2.9 |
GO:1990379 |
lipid transport across blood brain barrier(GO:1990379) |
| 2.9 |
14.6 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 2.9 |
14.5 |
GO:1903598 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) positive regulation of gap junction assembly(GO:1903598) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 2.9 |
5.8 |
GO:0070296 |
sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 2.9 |
14.4 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 2.9 |
11.5 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 2.8 |
17.0 |
GO:1902998 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 2.8 |
2.8 |
GO:0098908 |
regulation of neuronal action potential(GO:0098908) |
| 2.8 |
19.7 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 2.8 |
8.4 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 2.8 |
8.4 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 2.8 |
13.9 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 2.7 |
8.2 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 2.7 |
2.7 |
GO:0070366 |
regulation of hepatocyte differentiation(GO:0070366) |
| 2.7 |
21.4 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 2.7 |
24.0 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 2.7 |
13.3 |
GO:0075136 |
response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 2.6 |
10.6 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 2.6 |
7.9 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 2.6 |
7.9 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 2.6 |
2.6 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 2.6 |
15.5 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 2.5 |
7.6 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 2.5 |
12.5 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 2.5 |
4.9 |
GO:0099566 |
regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 2.5 |
14.8 |
GO:0032811 |
negative regulation of epinephrine secretion(GO:0032811) |
| 2.4 |
4.9 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) |
| 2.4 |
4.8 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 2.4 |
7.2 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 2.4 |
7.2 |
GO:1903538 |
meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 2.4 |
21.4 |
GO:1900034 |
regulation of cellular response to heat(GO:1900034) |
| 2.4 |
4.7 |
GO:0021886 |
hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 2.4 |
14.2 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 2.4 |
7.1 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 2.4 |
2.4 |
GO:0003057 |
regulation of the force of heart contraction by chemical signal(GO:0003057) |
| 2.4 |
11.8 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 2.3 |
4.7 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 2.3 |
7.0 |
GO:1905169 |
protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
| 2.3 |
6.8 |
GO:1905072 |
cardiac jelly development(GO:1905072) |
| 2.3 |
9.0 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 2.2 |
6.7 |
GO:0051940 |
regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
| 2.2 |
8.9 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 2.2 |
8.7 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 2.2 |
10.8 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 2.2 |
4.3 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 2.2 |
25.9 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 2.2 |
2.2 |
GO:0071317 |
cellular response to isoquinoline alkaloid(GO:0071317) |
| 2.2 |
2.2 |
GO:2000345 |
regulation of hepatocyte proliferation(GO:2000345) |
| 2.1 |
8.6 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 2.1 |
6.4 |
GO:0060437 |
lung growth(GO:0060437) |
| 2.1 |
8.6 |
GO:0061526 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
| 2.1 |
19.2 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 2.1 |
6.4 |
GO:1902219 |
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 2.1 |
2.1 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 2.1 |
6.3 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 2.1 |
8.4 |
GO:0010985 |
negative regulation of lipoprotein particle clearance(GO:0010985) negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 2.1 |
6.3 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 2.1 |
6.3 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 2.1 |
6.3 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 2.1 |
8.3 |
GO:0021586 |
pons maturation(GO:0021586) |
| 2.1 |
18.7 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 2.1 |
8.3 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 2.1 |
8.3 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 2.0 |
4.1 |
GO:0030815 |
negative regulation of cAMP metabolic process(GO:0030815) |
| 2.0 |
2.0 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 2.0 |
8.2 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 2.0 |
6.1 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 2.0 |
2.0 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 2.0 |
2.0 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 2.0 |
6.0 |
GO:0019043 |
establishment of viral latency(GO:0019043) |
| 2.0 |
2.0 |
GO:0002931 |
response to ischemia(GO:0002931) |
| 2.0 |
5.9 |
GO:0099548 |
trans-synaptic signaling by nitric oxide(GO:0099548) |
| 1.9 |
3.9 |
GO:0061744 |
motor behavior(GO:0061744) |
| 1.9 |
5.7 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 1.9 |
11.5 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 1.9 |
9.5 |
GO:2001025 |
positive regulation of response to drug(GO:2001025) |
| 1.9 |
5.7 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 1.9 |
17.1 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 1.9 |
18.8 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 1.9 |
13.1 |
GO:0098909 |
regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 1.9 |
1.9 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 1.9 |
3.7 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 1.9 |
5.6 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 1.9 |
5.6 |
GO:0010248 |
B cell negative selection(GO:0002352) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 1.9 |
1.9 |
GO:0014048 |
regulation of glutamate secretion(GO:0014048) |
| 1.8 |
7.4 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 1.8 |
5.5 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 1.8 |
5.5 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 1.8 |
22.1 |
GO:0031645 |
negative regulation of neurological system process(GO:0031645) |
| 1.8 |
7.3 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 1.8 |
5.5 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 1.8 |
5.4 |
GO:0072180 |
mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 1.8 |
1.8 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 1.8 |
10.8 |
GO:0070294 |
renal sodium ion absorption(GO:0070294) |
| 1.8 |
1.8 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 1.8 |
5.4 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 1.8 |
3.6 |
GO:2000705 |
regulation of dense core granule biogenesis(GO:2000705) |
| 1.8 |
8.9 |
GO:0003025 |
regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 1.8 |
3.5 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 1.8 |
5.3 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 1.8 |
1.8 |
GO:1902473 |
regulation of protein localization to synapse(GO:1902473) |
| 1.8 |
8.8 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 1.8 |
1.8 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 1.8 |
1.8 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 1.8 |
19.3 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 1.8 |
3.5 |
GO:0035026 |
leading edge cell differentiation(GO:0035026) |
| 1.7 |
1.7 |
GO:1903976 |
negative regulation of glial cell migration(GO:1903976) |
| 1.7 |
1.7 |
GO:1900108 |
negative regulation of nodal signaling pathway(GO:1900108) |
| 1.7 |
5.2 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 1.7 |
5.2 |
GO:0010752 |
regulation of cGMP-mediated signaling(GO:0010752) |
| 1.7 |
1.7 |
GO:2000209 |
regulation of anoikis(GO:2000209) |
| 1.7 |
6.9 |
GO:2000562 |
negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 1.7 |
5.2 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 1.7 |
15.4 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 1.7 |
6.8 |
GO:1901166 |
neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 1.7 |
5.0 |
GO:0051715 |
cytolysis in other organism(GO:0051715) |
| 1.7 |
51.7 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 1.7 |
13.2 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 1.7 |
1.7 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 1.6 |
1.6 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 1.6 |
4.9 |
GO:0061623 |
glycolytic process from galactose(GO:0061623) |
| 1.6 |
11.5 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 1.6 |
11.5 |
GO:0002283 |
neutrophil activation involved in immune response(GO:0002283) |
| 1.6 |
8.2 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 1.6 |
3.3 |
GO:0031394 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 1.6 |
3.2 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 1.6 |
3.2 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 1.6 |
17.6 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 1.6 |
4.8 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 1.6 |
17.6 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 1.6 |
4.8 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 1.6 |
8.0 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 1.6 |
4.8 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 1.6 |
6.3 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 1.6 |
3.2 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 1.6 |
4.7 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 1.6 |
9.5 |
GO:0032796 |
uropod organization(GO:0032796) |
| 1.6 |
1.6 |
GO:0034124 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 1.6 |
3.1 |
GO:1903596 |
regulation of gap junction assembly(GO:1903596) |
| 1.6 |
1.6 |
GO:1903294 |
regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
| 1.6 |
6.2 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 1.6 |
3.1 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 1.6 |
3.1 |
GO:0010046 |
response to mycotoxin(GO:0010046) |
| 1.6 |
12.4 |
GO:0032341 |
mineralocorticoid metabolic process(GO:0008212) aldosterone metabolic process(GO:0032341) |
| 1.5 |
1.5 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 1.5 |
7.7 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 1.5 |
6.2 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 1.5 |
1.5 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 1.5 |
4.6 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 1.5 |
6.1 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 1.5 |
4.6 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 1.5 |
13.8 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 1.5 |
1.5 |
GO:0007619 |
courtship behavior(GO:0007619) |
| 1.5 |
3.0 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 1.5 |
4.6 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 1.5 |
13.7 |
GO:0014824 |
artery smooth muscle contraction(GO:0014824) |
| 1.5 |
4.6 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 1.5 |
3.0 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 1.5 |
4.5 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 1.5 |
1.5 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 1.5 |
6.0 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 1.5 |
18.0 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 1.5 |
3.0 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 1.5 |
4.5 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.5 |
16.5 |
GO:2000580 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 1.5 |
1.5 |
GO:0051590 |
positive regulation of neurotransmitter transport(GO:0051590) |
| 1.5 |
7.4 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 1.5 |
4.5 |
GO:0009946 |
proximal/distal axis specification(GO:0009946) neuroblast migration(GO:0097402) |
| 1.5 |
4.5 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 1.5 |
1.5 |
GO:0061743 |
motor learning(GO:0061743) |
| 1.5 |
7.4 |
GO:0003093 |
regulation of glomerular filtration(GO:0003093) |
| 1.5 |
10.3 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 1.5 |
1.5 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 1.5 |
1.5 |
GO:0099563 |
modification of synaptic structure(GO:0099563) |
| 1.5 |
5.8 |
GO:2001245 |
regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 1.5 |
13.1 |
GO:0033008 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 1.5 |
7.3 |
GO:0032497 |
detection of lipopolysaccharide(GO:0032497) |
| 1.5 |
4.4 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 1.5 |
2.9 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 1.4 |
4.3 |
GO:0072737 |
response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 1.4 |
4.3 |
GO:0048597 |
post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 1.4 |
2.9 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 1.4 |
2.8 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 1.4 |
4.3 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 1.4 |
5.7 |
GO:0015825 |
L-serine transport(GO:0015825) |
| 1.4 |
1.4 |
GO:0099552 |
trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 1.4 |
5.7 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 1.4 |
5.7 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 1.4 |
2.8 |
GO:0002513 |
tolerance induction to self antigen(GO:0002513) |
| 1.4 |
5.6 |
GO:2000987 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 1.4 |
1.4 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 1.4 |
4.2 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 1.4 |
9.8 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 1.4 |
4.2 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 1.4 |
5.5 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 1.4 |
15.2 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 1.4 |
2.8 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 1.4 |
2.8 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 1.4 |
2.7 |
GO:0035963 |
response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 1.4 |
8.2 |
GO:0032439 |
endosome localization(GO:0032439) |
| 1.4 |
4.1 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 1.4 |
4.1 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 1.3 |
2.7 |
GO:1901731 |
positive regulation of platelet aggregation(GO:1901731) |
| 1.3 |
17.5 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 1.3 |
1.3 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 1.3 |
5.4 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 1.3 |
2.7 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 1.3 |
4.0 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 1.3 |
24.0 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 1.3 |
5.3 |
GO:0042822 |
pyridoxal phosphate metabolic process(GO:0042822) |
| 1.3 |
14.5 |
GO:0015816 |
glycine transport(GO:0015816) |
| 1.3 |
2.6 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 1.3 |
5.2 |
GO:0006848 |
pyruvate transport(GO:0006848) |
| 1.3 |
3.9 |
GO:0030974 |
thiamine pyrophosphate transport(GO:0030974) |
| 1.3 |
3.9 |
GO:0099590 |
neurotransmitter receptor internalization(GO:0099590) |
| 1.3 |
3.9 |
GO:0080184 |
response to stilbenoid(GO:0035634) response to phenylpropanoid(GO:0080184) |
| 1.3 |
2.6 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 1.3 |
5.2 |
GO:0060768 |
regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 1.3 |
3.9 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 1.3 |
1.3 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 1.3 |
6.5 |
GO:1903181 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 1.3 |
5.1 |
GO:0042045 |
epithelial fluid transport(GO:0042045) |
| 1.3 |
3.8 |
GO:0034035 |
sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 1.3 |
14.1 |
GO:1903861 |
positive regulation of dendrite extension(GO:1903861) |
| 1.3 |
2.6 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
| 1.3 |
1.3 |
GO:0045136 |
development of secondary sexual characteristics(GO:0045136) |
| 1.3 |
37.9 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 1.3 |
1.3 |
GO:2000670 |
positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 1.3 |
3.8 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 1.3 |
3.8 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 1.3 |
1.3 |
GO:0035249 |
synaptic transmission, glutamatergic(GO:0035249) |
| 1.3 |
3.8 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
| 1.3 |
32.5 |
GO:0015991 |
ATP hydrolysis coupled proton transport(GO:0015991) |
| 1.2 |
7.5 |
GO:0070474 |
positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 1.2 |
16.1 |
GO:0099628 |
receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
| 1.2 |
6.2 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 1.2 |
7.4 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 1.2 |
1.2 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 1.2 |
4.9 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 1.2 |
1.2 |
GO:0001767 |
establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
| 1.2 |
7.4 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 1.2 |
1.2 |
GO:0032829 |
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
| 1.2 |
3.7 |
GO:0009826 |
unidimensional cell growth(GO:0009826) |
| 1.2 |
6.1 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 1.2 |
9.8 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 1.2 |
3.7 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 1.2 |
1.2 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 1.2 |
6.1 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 1.2 |
3.6 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.2 |
6.0 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 1.2 |
3.6 |
GO:0048866 |
stem cell fate specification(GO:0048866) |
| 1.2 |
22.8 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 1.2 |
4.8 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 1.2 |
4.8 |
GO:1900110 |
negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 1.2 |
3.6 |
GO:0006244 |
pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 1.2 |
6.0 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 1.2 |
4.8 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 1.2 |
3.6 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 1.2 |
2.4 |
GO:1905247 |
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 1.2 |
11.8 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 1.2 |
4.7 |
GO:0045630 |
positive regulation of T-helper 2 cell differentiation(GO:0045630) |
| 1.2 |
2.3 |
GO:0050904 |
diapedesis(GO:0050904) |
| 1.2 |
26.9 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 1.2 |
14.0 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 1.2 |
2.3 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 1.2 |
5.8 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 1.2 |
3.5 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 1.2 |
8.1 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 1.2 |
4.6 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 1.2 |
4.6 |
GO:0009448 |
gamma-aminobutyric acid metabolic process(GO:0009448) |
| 1.2 |
2.3 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 1.2 |
2.3 |
GO:0019081 |
viral translation(GO:0019081) viral translational termination-reinitiation(GO:0075525) |
| 1.1 |
2.3 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 1.1 |
20.5 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 1.1 |
5.7 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 1.1 |
5.7 |
GO:0014050 |
negative regulation of glutamate secretion(GO:0014050) |
| 1.1 |
3.4 |
GO:0030070 |
insulin processing(GO:0030070) |
| 1.1 |
3.4 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 1.1 |
3.4 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 1.1 |
11.3 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 1.1 |
1.1 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 1.1 |
3.4 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 1.1 |
4.5 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 1.1 |
22.3 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 1.1 |
5.6 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 1.1 |
1.1 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 1.1 |
3.3 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 1.1 |
1.1 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 1.1 |
2.2 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 1.1 |
1.1 |
GO:0071280 |
cellular response to copper ion(GO:0071280) |
| 1.1 |
5.5 |
GO:0033031 |
positive regulation of neutrophil apoptotic process(GO:0033031) |
| 1.1 |
2.2 |
GO:0010572 |
positive regulation of platelet activation(GO:0010572) |
| 1.1 |
4.3 |
GO:0033600 |
negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 1.1 |
7.6 |
GO:1903874 |
ferrous iron transmembrane transport(GO:1903874) |
| 1.1 |
4.3 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 1.1 |
3.2 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 1.1 |
5.3 |
GO:1902172 |
keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 1.1 |
14.9 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 1.1 |
2.1 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 1.1 |
6.4 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 1.1 |
4.3 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 1.1 |
2.1 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 1.1 |
2.1 |
GO:0045915 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 1.1 |
5.3 |
GO:0019659 |
fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 1.1 |
1.1 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 1.1 |
4.2 |
GO:0009227 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 1.1 |
13.7 |
GO:1901898 |
negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 1.1 |
2.1 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 1.1 |
2.1 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 1.0 |
3.1 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 1.0 |
1.0 |
GO:0034694 |
response to prostaglandin(GO:0034694) response to prostaglandin E(GO:0034695) |
| 1.0 |
2.1 |
GO:0001803 |
type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
| 1.0 |
1.0 |
GO:0048611 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 1.0 |
1.0 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 1.0 |
2.1 |
GO:1902608 |
regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
| 1.0 |
1.0 |
GO:0072203 |
cell proliferation involved in metanephros development(GO:0072203) |
| 1.0 |
1.0 |
GO:0045672 |
positive regulation of osteoclast differentiation(GO:0045672) |
| 1.0 |
2.1 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 1.0 |
10.3 |
GO:0001765 |
membrane raft assembly(GO:0001765) |
| 1.0 |
9.2 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 1.0 |
2.0 |
GO:0021826 |
substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
| 1.0 |
11.2 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 1.0 |
1.0 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 1.0 |
2.0 |
GO:0070471 |
uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) |
| 1.0 |
7.1 |
GO:0015862 |
uridine transport(GO:0015862) |
| 1.0 |
4.0 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 1.0 |
7.1 |
GO:0061620 |
glycolytic process through glucose-6-phosphate(GO:0061620) |
| 1.0 |
1.0 |
GO:1904058 |
positive regulation of sensory perception of pain(GO:1904058) |
| 1.0 |
5.0 |
GO:1903795 |
regulation of inorganic anion transmembrane transport(GO:1903795) |
| 1.0 |
8.0 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 1.0 |
15.0 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 1.0 |
3.0 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 1.0 |
10.0 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 1.0 |
3.0 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) |
| 1.0 |
1.0 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 1.0 |
6.0 |
GO:0055064 |
chloride ion homeostasis(GO:0055064) |
| 1.0 |
4.0 |
GO:1990845 |
adaptive thermogenesis(GO:1990845) |
| 1.0 |
1.0 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 1.0 |
3.0 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 1.0 |
1.0 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 1.0 |
1.0 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 1.0 |
8.8 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 1.0 |
1.0 |
GO:0033033 |
negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 1.0 |
2.0 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 1.0 |
6.8 |
GO:0015961 |
diadenosine polyphosphate catabolic process(GO:0015961) |
| 1.0 |
2.0 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 1.0 |
2.9 |
GO:0071707 |
immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 1.0 |
1.9 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 1.0 |
3.9 |
GO:0000189 |
MAPK import into nucleus(GO:0000189) |
| 1.0 |
3.9 |
GO:0014848 |
urinary tract smooth muscle contraction(GO:0014848) |
| 1.0 |
1.0 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 1.0 |
5.8 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 1.0 |
5.8 |
GO:0046103 |
inosine biosynthetic process(GO:0046103) |
| 1.0 |
4.9 |
GO:0051004 |
regulation of lipoprotein lipase activity(GO:0051004) |
| 1.0 |
3.9 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 1.0 |
2.9 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 1.0 |
5.8 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 1.0 |
5.8 |
GO:0031424 |
keratinization(GO:0031424) |
| 1.0 |
3.8 |
GO:0046709 |
IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 1.0 |
1.9 |
GO:0060012 |
synaptic transmission, glycinergic(GO:0060012) |
| 1.0 |
3.8 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 1.0 |
7.6 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 1.0 |
1.0 |
GO:1904008 |
response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 1.0 |
1.9 |
GO:2000319 |
negative regulation of T-helper 17 type immune response(GO:2000317) regulation of T-helper 17 cell differentiation(GO:2000319) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 1.0 |
3.8 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.9 |
3.8 |
GO:0002922 |
positive regulation of humoral immune response(GO:0002922) |
| 0.9 |
2.8 |
GO:0000448 |
cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.9 |
3.8 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.9 |
3.8 |
GO:0010813 |
neuropeptide catabolic process(GO:0010813) |
| 0.9 |
6.6 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.9 |
31.0 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.9 |
0.9 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.9 |
4.7 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.9 |
3.7 |
GO:0016128 |
phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.9 |
2.8 |
GO:0010958 |
regulation of amino acid import(GO:0010958) |
| 0.9 |
18.7 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.9 |
0.9 |
GO:0060913 |
cardiac cell fate determination(GO:0060913) |
| 0.9 |
3.7 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.9 |
5.5 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.9 |
7.4 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.9 |
2.8 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.9 |
0.9 |
GO:0045575 |
basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
| 0.9 |
3.7 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.9 |
1.8 |
GO:0035812 |
renal sodium excretion(GO:0035812) |
| 0.9 |
0.9 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.9 |
3.7 |
GO:0033580 |
protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.9 |
2.7 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.9 |
5.5 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.9 |
0.9 |
GO:0033003 |
regulation of mast cell activation(GO:0033003) |
| 0.9 |
3.6 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.9 |
12.7 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.9 |
0.9 |
GO:0018307 |
enzyme active site formation(GO:0018307) |
| 0.9 |
0.9 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.9 |
1.8 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.9 |
1.8 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.9 |
0.9 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.9 |
5.4 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.9 |
1.8 |
GO:0099550 |
trans-synaptic signalling, modulating synaptic transmission(GO:0099550) |
| 0.9 |
1.8 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 0.9 |
2.7 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.9 |
4.5 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.9 |
2.7 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
| 0.9 |
0.9 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.9 |
0.9 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 0.9 |
4.5 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.9 |
0.9 |
GO:0014719 |
skeletal muscle satellite cell activation(GO:0014719) |
| 0.9 |
3.6 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 0.9 |
3.6 |
GO:0007066 |
female meiosis sister chromatid cohesion(GO:0007066) |
| 0.9 |
2.7 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.9 |
0.9 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.9 |
1.8 |
GO:2000016 |
negative regulation of determination of dorsal identity(GO:2000016) |
| 0.9 |
8.0 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.9 |
0.9 |
GO:0031077 |
post-embryonic camera-type eye development(GO:0031077) |
| 0.9 |
0.9 |
GO:2000468 |
regulation of peroxidase activity(GO:2000468) |
| 0.9 |
11.5 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.9 |
4.4 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.9 |
1.8 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.9 |
8.7 |
GO:0098877 |
neurotransmitter receptor transport to plasma membrane(GO:0098877) |
| 0.9 |
0.9 |
GO:2000138 |
positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.9 |
11.2 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.9 |
2.6 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 0.9 |
11.2 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.9 |
1.7 |
GO:0090500 |
endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.9 |
0.9 |
GO:0060161 |
positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.9 |
3.4 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.9 |
2.6 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.9 |
3.4 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.9 |
3.4 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.9 |
2.6 |
GO:0015960 |
diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.9 |
1.7 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.9 |
0.9 |
GO:0061218 |
negative regulation of mesonephros development(GO:0061218) |
| 0.9 |
4.3 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.9 |
0.9 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.9 |
0.9 |
GO:0048550 |
negative regulation of pinocytosis(GO:0048550) |
| 0.9 |
1.7 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
| 0.9 |
3.4 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.8 |
0.8 |
GO:1904861 |
excitatory synapse assembly(GO:1904861) |
| 0.8 |
2.5 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.8 |
0.8 |
GO:0042182 |
ketone catabolic process(GO:0042182) |
| 0.8 |
0.8 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.8 |
0.8 |
GO:0061450 |
trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
| 0.8 |
8.4 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.8 |
1.7 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.8 |
2.5 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.8 |
3.3 |
GO:1903207 |
neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 0.8 |
0.8 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.8 |
3.3 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.8 |
1.7 |
GO:0051204 |
protein insertion into mitochondrial membrane(GO:0051204) |
| 0.8 |
0.8 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.8 |
1.7 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.8 |
0.8 |
GO:2001187 |
positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.8 |
1.7 |
GO:0061588 |
calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.8 |
9.9 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.8 |
6.6 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.8 |
3.3 |
GO:0032276 |
regulation of gonadotropin secretion(GO:0032276) |
| 0.8 |
0.8 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.8 |
3.3 |
GO:0048715 |
negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 0.8 |
0.8 |
GO:0055078 |
sodium ion homeostasis(GO:0055078) |
| 0.8 |
3.3 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.8 |
4.1 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.8 |
0.8 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.8 |
2.4 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.8 |
3.3 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.8 |
6.5 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.8 |
4.9 |
GO:0051968 |
positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.8 |
3.2 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.8 |
2.4 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.8 |
1.6 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.8 |
0.8 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.8 |
1.6 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.8 |
6.4 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.8 |
3.2 |
GO:1900242 |
regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.8 |
4.0 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.8 |
3.2 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.8 |
3.2 |
GO:0071236 |
cellular response to antibiotic(GO:0071236) |
| 0.8 |
0.8 |
GO:1900127 |
positive regulation of hyaluronan biosynthetic process(GO:1900127) |
| 0.8 |
0.8 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.8 |
2.4 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.8 |
4.8 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.8 |
0.8 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.8 |
2.4 |
GO:0072081 |
proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
| 0.8 |
0.8 |
GO:0046037 |
GMP metabolic process(GO:0046037) |
| 0.8 |
1.6 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.8 |
4.7 |
GO:0046490 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.8 |
17.3 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.8 |
1.6 |
GO:0043084 |
penile erection(GO:0043084) |
| 0.8 |
5.5 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.8 |
3.1 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.8 |
2.3 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.8 |
4.7 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.8 |
5.4 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.8 |
2.3 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.8 |
2.3 |
GO:0032225 |
regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 0.8 |
0.8 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.8 |
7.0 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.8 |
2.3 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.8 |
6.2 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.8 |
3.1 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.8 |
0.8 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.8 |
0.8 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.8 |
1.5 |
GO:0033092 |
positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.8 |
3.1 |
GO:0010765 |
positive regulation of sodium ion transport(GO:0010765) |
| 0.8 |
1.5 |
GO:0072720 |
response to dithiothreitol(GO:0072720) |
| 0.8 |
0.8 |
GO:0001912 |
positive regulation of leukocyte mediated cytotoxicity(GO:0001912) |
| 0.8 |
3.8 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.8 |
2.3 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.8 |
1.5 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.8 |
2.3 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 0.8 |
8.3 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.8 |
6.0 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.8 |
3.8 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.8 |
2.3 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 0.8 |
0.8 |
GO:1903722 |
regulation of centriole elongation(GO:1903722) |
| 0.8 |
1.5 |
GO:0072103 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.8 |
1.5 |
GO:0015866 |
ADP transport(GO:0015866) |
| 0.7 |
0.7 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 0.7 |
3.7 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.7 |
10.5 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.7 |
2.2 |
GO:1900149 |
positive regulation of Schwann cell migration(GO:1900149) |
| 0.7 |
5.2 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.7 |
0.7 |
GO:0038171 |
cannabinoid signaling pathway(GO:0038171) |
| 0.7 |
2.2 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.7 |
1.5 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.7 |
0.7 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.7 |
0.7 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.7 |
3.7 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.7 |
6.6 |
GO:2000489 |
hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
| 0.7 |
2.2 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.7 |
2.9 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.7 |
7.3 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.7 |
3.6 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.7 |
2.9 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.7 |
2.2 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.7 |
3.6 |
GO:0072268 |
pattern specification involved in metanephros development(GO:0072268) |
| 0.7 |
1.5 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.7 |
13.1 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.7 |
2.2 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.7 |
1.4 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.7 |
2.2 |
GO:0006226 |
dUMP biosynthetic process(GO:0006226) |
| 0.7 |
1.4 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.7 |
4.3 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.7 |
5.0 |
GO:0042311 |
vasodilation(GO:0042311) |
| 0.7 |
1.4 |
GO:0006550 |
isoleucine catabolic process(GO:0006550) |
| 0.7 |
5.0 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.7 |
1.4 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.7 |
2.9 |
GO:0071726 |
response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.7 |
2.9 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.7 |
2.9 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.7 |
3.6 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.7 |
2.1 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.7 |
0.7 |
GO:0090035 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.7 |
0.7 |
GO:0002888 |
positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
| 0.7 |
0.7 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.7 |
2.8 |
GO:0019346 |
homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.7 |
2.1 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.7 |
2.8 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.7 |
2.8 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.7 |
7.8 |
GO:1905216 |
positive regulation of RNA binding(GO:1905216) |
| 0.7 |
4.2 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.7 |
0.7 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.7 |
2.8 |
GO:0006751 |
glutathione catabolic process(GO:0006751) |
| 0.7 |
2.1 |
GO:0097154 |
GABAergic neuron differentiation(GO:0097154) |
| 0.7 |
6.3 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.7 |
3.5 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.7 |
2.1 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.7 |
2.1 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.7 |
2.1 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.7 |
0.7 |
GO:0002677 |
negative regulation of chronic inflammatory response(GO:0002677) |
| 0.7 |
2.1 |
GO:0070346 |
positive regulation of fat cell proliferation(GO:0070346) |
| 0.7 |
2.1 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.7 |
6.3 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.7 |
1.4 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.7 |
2.1 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.7 |
0.7 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.7 |
0.7 |
GO:0015870 |
acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.7 |
0.7 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.7 |
0.7 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.7 |
0.7 |
GO:2000435 |
regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.7 |
2.7 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) |
| 0.7 |
7.5 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.7 |
2.7 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.7 |
1.4 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.7 |
3.4 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.7 |
0.7 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.7 |
10.2 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.7 |
2.0 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.7 |
9.5 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.7 |
9.5 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.7 |
0.7 |
GO:0009169 |
purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
| 0.7 |
2.0 |
GO:0043416 |
regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.7 |
3.4 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.7 |
2.0 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.7 |
4.7 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.7 |
4.7 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.7 |
0.7 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.7 |
2.7 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.7 |
2.0 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.7 |
0.7 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 0.7 |
0.7 |
GO:0007343 |
egg activation(GO:0007343) |
| 0.7 |
2.0 |
GO:0046016 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.7 |
0.7 |
GO:1904809 |
dense core granule localization(GO:0032253) dense core granule transport(GO:1901950) regulation of dense core granule transport(GO:1904809) positive regulation of dense core granule transport(GO:1904811) |
| 0.7 |
2.0 |
GO:1900226 |
negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.7 |
1.3 |
GO:0045684 |
positive regulation of epidermis development(GO:0045684) |
| 0.7 |
0.7 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
| 0.6 |
0.6 |
GO:0042368 |
negative regulation of vitamin D biosynthetic process(GO:0010957) vitamin D biosynthetic process(GO:0042368) negative regulation of vitamin metabolic process(GO:0046137) regulation of vitamin D biosynthetic process(GO:0060556) |
| 0.6 |
25.9 |
GO:0097031 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.6 |
11.6 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.6 |
0.6 |
GO:0002481 |
antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
| 0.6 |
2.6 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.6 |
1.3 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.6 |
4.5 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.6 |
0.6 |
GO:0061535 |
glutamate secretion, neurotransmission(GO:0061535) |
| 0.6 |
3.9 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.6 |
2.6 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.6 |
2.6 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.6 |
7.0 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.6 |
0.6 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.6 |
1.9 |
GO:0009838 |
abscission(GO:0009838) |
| 0.6 |
3.1 |
GO:1904721 |
regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.6 |
2.5 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.6 |
2.5 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.6 |
0.6 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.6 |
1.2 |
GO:0061357 |
Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.6 |
5.0 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.6 |
2.5 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.6 |
1.9 |
GO:1902310 |
regulation of peptidyl-serine dephosphorylation(GO:1902308) positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.6 |
3.1 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.6 |
1.9 |
GO:0051531 |
NFAT protein import into nucleus(GO:0051531) |
| 0.6 |
1.9 |
GO:1904528 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.6 |
3.1 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.6 |
4.9 |
GO:0071816 |
tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.6 |
3.7 |
GO:0000466 |
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.6 |
7.3 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.6 |
4.9 |
GO:0042346 |
positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.6 |
1.8 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.6 |
5.5 |
GO:0010543 |
regulation of platelet activation(GO:0010543) |
| 0.6 |
2.4 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.6 |
1.2 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.6 |
2.4 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.6 |
3.6 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
| 0.6 |
0.6 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.6 |
0.6 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.6 |
0.6 |
GO:0002042 |
cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.6 |
2.4 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 0.6 |
3.6 |
GO:0071035 |
nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
| 0.6 |
4.2 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.6 |
3.0 |
GO:0006586 |
tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
| 0.6 |
0.6 |
GO:0032095 |
regulation of response to food(GO:0032095) |
| 0.6 |
1.8 |
GO:0019400 |
alditol metabolic process(GO:0019400) |
| 0.6 |
3.0 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.6 |
1.8 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.6 |
0.6 |
GO:0048014 |
Tie signaling pathway(GO:0048014) |
| 0.6 |
1.8 |
GO:0044861 |
protein localization to plasma membrane raft(GO:0044860) protein transport into plasma membrane raft(GO:0044861) |
| 0.6 |
1.8 |
GO:0072014 |
proximal tubule development(GO:0072014) |
| 0.6 |
2.3 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.6 |
5.3 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.6 |
3.5 |
GO:0042092 |
type 2 immune response(GO:0042092) |
| 0.6 |
1.2 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.6 |
7.0 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.6 |
1.2 |
GO:1901526 |
positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.6 |
4.1 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.6 |
0.6 |
GO:1901631 |
positive regulation of presynaptic membrane organization(GO:1901631) |
| 0.6 |
0.6 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.6 |
0.6 |
GO:1903305 |
regulation of regulated secretory pathway(GO:1903305) |
| 0.6 |
0.6 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.6 |
11.5 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.6 |
2.3 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.6 |
2.3 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.6 |
0.6 |
GO:0010455 |
positive regulation of cell fate commitment(GO:0010455) |
| 0.6 |
2.3 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.6 |
2.3 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.6 |
5.1 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.6 |
1.1 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.6 |
1.7 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.6 |
28.2 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.6 |
1.1 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.6 |
0.6 |
GO:1990441 |
negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
| 0.6 |
1.7 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.6 |
3.4 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.6 |
1.1 |
GO:0032510 |
endosome transport via multivesicular body sorting pathway(GO:0032509) endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.6 |
2.8 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.6 |
10.6 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.6 |
1.7 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.6 |
1.1 |
GO:0010700 |
negative regulation of norepinephrine secretion(GO:0010700) |
| 0.6 |
1.1 |
GO:2000650 |
negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
| 0.6 |
1.7 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.6 |
3.9 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.6 |
2.8 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.5 |
4.9 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.5 |
1.6 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.5 |
3.3 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.5 |
3.3 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.5 |
1.6 |
GO:0072717 |
cellular response to actinomycin D(GO:0072717) |
| 0.5 |
2.2 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.5 |
1.1 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.5 |
5.4 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.5 |
0.5 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.5 |
2.7 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.5 |
0.5 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) |
| 0.5 |
1.1 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.5 |
4.3 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.5 |
4.8 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.5 |
10.7 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.5 |
0.5 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
| 0.5 |
0.5 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.5 |
5.3 |
GO:0033599 |
regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.5 |
1.6 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.5 |
1.1 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.5 |
2.1 |
GO:0009113 |
purine nucleobase biosynthetic process(GO:0009113) |
| 0.5 |
3.2 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.5 |
1.1 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.5 |
2.1 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.5 |
2.1 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.5 |
1.6 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.5 |
0.5 |
GO:0007196 |
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.5 |
4.2 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.5 |
6.8 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.5 |
6.3 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.5 |
2.6 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.5 |
3.6 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
| 0.5 |
14.5 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.5 |
1.6 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.5 |
2.1 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.5 |
3.1 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.5 |
20.6 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.5 |
1.0 |
GO:0006497 |
protein lipidation(GO:0006497) lipoprotein biosynthetic process(GO:0042158) |
| 0.5 |
1.0 |
GO:0045324 |
late endosome to vacuole transport(GO:0045324) |
| 0.5 |
1.0 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 0.5 |
1.0 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.5 |
0.5 |
GO:1903975 |
regulation of glial cell migration(GO:1903975) |
| 0.5 |
2.1 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.5 |
4.6 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.5 |
3.1 |
GO:0006623 |
protein targeting to vacuole(GO:0006623) |
| 0.5 |
0.5 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.5 |
6.6 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.5 |
8.2 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.5 |
1.0 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.5 |
1.5 |
GO:1904729 |
regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
| 0.5 |
0.5 |
GO:2001015 |
negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.5 |
5.6 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.5 |
4.0 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.5 |
4.5 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.5 |
1.0 |
GO:0006702 |
androgen biosynthetic process(GO:0006702) |
| 0.5 |
1.5 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.5 |
2.0 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.5 |
2.0 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.5 |
3.5 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.5 |
1.0 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 0.5 |
10.0 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.5 |
6.5 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.5 |
5.0 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.5 |
0.5 |
GO:0009226 |
nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.5 |
1.0 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 0.5 |
32.3 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.5 |
1.5 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.5 |
2.0 |
GO:0002861 |
regulation of inflammatory response to antigenic stimulus(GO:0002861) |
| 0.5 |
2.0 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.5 |
2.5 |
GO:0036296 |
cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) |
| 0.5 |
4.4 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.5 |
1.5 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.5 |
1.0 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.5 |
0.5 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.5 |
1.0 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.5 |
1.9 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.5 |
4.4 |
GO:0032715 |
negative regulation of interleukin-6 production(GO:0032715) |
| 0.5 |
0.5 |
GO:0002636 |
positive regulation of germinal center formation(GO:0002636) |
| 0.5 |
9.2 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.5 |
4.4 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.5 |
3.4 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.5 |
1.0 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.5 |
1.4 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.5 |
2.4 |
GO:0010447 |
response to acidic pH(GO:0010447) |
| 0.5 |
1.0 |
GO:0035809 |
regulation of urine volume(GO:0035809) |
| 0.5 |
0.5 |
GO:1903421 |
regulation of synaptic vesicle recycling(GO:1903421) |
| 0.5 |
1.0 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.5 |
1.9 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.5 |
2.4 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.5 |
1.4 |
GO:0032682 |
negative regulation of chemokine production(GO:0032682) |
| 0.5 |
2.4 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.5 |
2.4 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.5 |
1.4 |
GO:0022615 |
protein to membrane docking(GO:0022615) |
| 0.5 |
4.3 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.5 |
0.9 |
GO:0044241 |
lipid digestion(GO:0044241) |
| 0.5 |
1.4 |
GO:1900060 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.5 |
2.8 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.5 |
2.4 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.5 |
0.5 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.5 |
1.4 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.5 |
0.9 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.5 |
16.8 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.5 |
3.7 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.5 |
1.4 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.5 |
5.6 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.5 |
1.4 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.5 |
2.3 |
GO:0060347 |
heart trabecula formation(GO:0060347) |
| 0.5 |
1.4 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.5 |
1.4 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.5 |
1.4 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.5 |
5.1 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.5 |
11.1 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.5 |
0.5 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.5 |
1.4 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.5 |
1.4 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.5 |
0.5 |
GO:0033140 |
regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.5 |
1.4 |
GO:1903223 |
positive regulation of oxidative stress-induced neuron death(GO:1903223) |
| 0.5 |
10.6 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.5 |
0.9 |
GO:0010641 |
positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 0.5 |
0.5 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.5 |
1.8 |
GO:0097484 |
dendrite extension(GO:0097484) |
| 0.5 |
1.4 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.5 |
0.5 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.5 |
0.5 |
GO:0044830 |
modulation by host of viral RNA genome replication(GO:0044830) |
| 0.5 |
2.3 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.4 |
2.7 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.4 |
5.4 |
GO:0015992 |
proton transport(GO:0015992) |
| 0.4 |
0.9 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.4 |
1.3 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.4 |
2.2 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.4 |
2.7 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.4 |
3.5 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.4 |
0.4 |
GO:0009125 |
nucleoside monophosphate catabolic process(GO:0009125) |
| 0.4 |
1.8 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.4 |
3.5 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.4 |
0.9 |
GO:0035696 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.4 |
1.7 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.4 |
5.2 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.4 |
1.3 |
GO:0042268 |
regulation of cytolysis(GO:0042268) positive regulation of cytolysis(GO:0045919) |
| 0.4 |
0.4 |
GO:0098928 |
presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 0.4 |
1.3 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.4 |
0.4 |
GO:0035937 |
estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
| 0.4 |
2.1 |
GO:0003253 |
cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
| 0.4 |
2.1 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.4 |
1.7 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.4 |
1.3 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.4 |
7.6 |
GO:0043949 |
regulation of cAMP-mediated signaling(GO:0043949) |
| 0.4 |
4.2 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.4 |
1.3 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.4 |
2.1 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.4 |
2.1 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.4 |
6.6 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 0.4 |
1.2 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.4 |
6.6 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.4 |
1.7 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.4 |
0.4 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.4 |
7.8 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.4 |
0.8 |
GO:1904742 |
regulation of telomeric DNA binding(GO:1904742) |
| 0.4 |
2.4 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.4 |
0.4 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.4 |
0.8 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.4 |
0.8 |
GO:0032070 |
regulation of deoxyribonuclease activity(GO:0032070) |
| 0.4 |
1.6 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.4 |
2.0 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.4 |
7.3 |
GO:0048662 |
negative regulation of smooth muscle cell proliferation(GO:0048662) |
| 0.4 |
0.8 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.4 |
0.8 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.4 |
3.2 |
GO:0019884 |
antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.4 |
0.8 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.4 |
0.4 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.4 |
2.8 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.4 |
2.0 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.4 |
7.2 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.4 |
2.8 |
GO:0003044 |
regulation of systemic arterial blood pressure mediated by a chemical signal(GO:0003044) |
| 0.4 |
1.2 |
GO:0043987 |
histone H3-S10 phosphorylation(GO:0043987) |
| 0.4 |
0.8 |
GO:0070230 |
positive regulation of lymphocyte apoptotic process(GO:0070230) positive regulation of T cell apoptotic process(GO:0070234) |
| 0.4 |
0.8 |
GO:0002484 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.4 |
1.6 |
GO:0060561 |
apoptotic process involved in morphogenesis(GO:0060561) |
| 0.4 |
0.8 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.4 |
3.9 |
GO:0031295 |
T cell costimulation(GO:0031295) |
| 0.4 |
3.1 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) |
| 0.4 |
1.2 |
GO:0048298 |
positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.4 |
0.4 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.4 |
1.2 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.4 |
3.1 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.4 |
1.6 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.4 |
0.8 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.4 |
0.4 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.4 |
2.3 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.4 |
1.2 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.4 |
3.4 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.4 |
0.4 |
GO:0021593 |
rhombomere morphogenesis(GO:0021593) |
| 0.4 |
0.4 |
GO:1904796 |
regulation of core promoter binding(GO:1904796) |
| 0.4 |
0.4 |
GO:0022028 |
tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
| 0.4 |
3.4 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.4 |
1.9 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.4 |
0.4 |
GO:0002176 |
male germ cell proliferation(GO:0002176) regulation of male germ cell proliferation(GO:2000254) |
| 0.4 |
2.2 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.4 |
1.9 |
GO:0002098 |
tRNA wobble uridine modification(GO:0002098) |
| 0.4 |
1.1 |
GO:0071276 |
cellular response to cadmium ion(GO:0071276) |
| 0.4 |
1.1 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.4 |
2.6 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.4 |
1.1 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.4 |
9.9 |
GO:0006779 |
porphyrin-containing compound biosynthetic process(GO:0006779) |
| 0.4 |
1.5 |
GO:0099527 |
postsynapse to nucleus signaling pathway(GO:0099527) |
| 0.4 |
2.2 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) |
| 0.4 |
0.4 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.4 |
2.2 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.4 |
0.7 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.4 |
1.8 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.4 |
1.1 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.4 |
0.4 |
GO:0001777 |
T cell homeostatic proliferation(GO:0001777) |
| 0.4 |
0.7 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.4 |
8.0 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.4 |
14.1 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.4 |
1.4 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
| 0.4 |
1.4 |
GO:2000002 |
negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.4 |
1.4 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.4 |
6.4 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.4 |
0.7 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.4 |
0.4 |
GO:0090135 |
actin filament branching(GO:0090135) |
| 0.4 |
1.4 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.4 |
1.4 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.4 |
0.7 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.3 |
0.3 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.3 |
1.0 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.3 |
0.3 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.3 |
0.3 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 0.3 |
0.3 |
GO:0002339 |
B cell selection(GO:0002339) |
| 0.3 |
1.0 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.3 |
2.4 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.3 |
2.4 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.3 |
2.0 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.3 |
0.3 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.3 |
0.3 |
GO:0002093 |
auditory receptor cell morphogenesis(GO:0002093) |
| 0.3 |
2.0 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.3 |
0.7 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.3 |
1.3 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.3 |
3.0 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.3 |
3.7 |
GO:0006743 |
ubiquinone metabolic process(GO:0006743) |
| 0.3 |
3.0 |
GO:0051703 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.3 |
0.7 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.3 |
3.3 |
GO:0046185 |
aldehyde catabolic process(GO:0046185) |
| 0.3 |
3.0 |
GO:0042168 |
heme metabolic process(GO:0042168) |
| 0.3 |
1.3 |
GO:0044803 |
multi-organism membrane organization(GO:0044803) |
| 0.3 |
1.0 |
GO:0015817 |
histidine transport(GO:0015817) |
| 0.3 |
0.7 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.3 |
0.7 |
GO:0060046 |
regulation of acrosome reaction(GO:0060046) |
| 0.3 |
4.2 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.3 |
3.3 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.3 |
2.6 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.3 |
2.0 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.3 |
3.2 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.3 |
0.3 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.3 |
0.3 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.3 |
6.1 |
GO:0043153 |
photoperiodism(GO:0009648) entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.3 |
0.6 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.3 |
1.9 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.3 |
3.2 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.3 |
2.6 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.3 |
0.6 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) |
| 0.3 |
3.2 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.3 |
4.1 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.3 |
0.9 |
GO:0050913 |
sensory perception of bitter taste(GO:0050913) |
| 0.3 |
18.8 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.3 |
9.0 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.3 |
0.6 |
GO:1902951 |
negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.3 |
2.2 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.3 |
1.9 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.3 |
0.3 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.3 |
3.4 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.3 |
0.6 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.3 |
1.8 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.3 |
4.3 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.3 |
0.6 |
GO:0034629 |
cellular protein complex localization(GO:0034629) |
| 0.3 |
4.0 |
GO:1901381 |
positive regulation of potassium ion transmembrane transport(GO:1901381) |
| 0.3 |
1.2 |
GO:1902340 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.3 |
1.5 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.3 |
1.8 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.3 |
4.3 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.3 |
0.6 |
GO:0002604 |
dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
| 0.3 |
0.6 |
GO:0007620 |
copulation(GO:0007620) |
| 0.3 |
0.6 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.3 |
0.6 |
GO:1904751 |
positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.3 |
7.0 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.3 |
1.2 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.3 |
1.2 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.3 |
3.6 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.3 |
3.3 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.3 |
1.8 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
| 0.3 |
0.6 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.3 |
2.7 |
GO:0032720 |
negative regulation of tumor necrosis factor production(GO:0032720) |
| 0.3 |
3.0 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.3 |
0.6 |
GO:1902074 |
response to salt(GO:1902074) |
| 0.3 |
0.6 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
| 0.3 |
0.3 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.3 |
0.3 |
GO:1904749 |
regulation of protein localization to nucleolus(GO:1904749) |
| 0.3 |
1.4 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.3 |
1.4 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.3 |
0.3 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.3 |
0.6 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.3 |
2.5 |
GO:0045806 |
negative regulation of endocytosis(GO:0045806) |
| 0.3 |
0.8 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.3 |
1.1 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.3 |
1.9 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.3 |
2.5 |
GO:0006047 |
UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.3 |
0.3 |
GO:1900109 |
regulation of histone H3-K9 dimethylation(GO:1900109) |
| 0.3 |
0.8 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.3 |
1.4 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.3 |
0.3 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.3 |
1.1 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.3 |
0.3 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.3 |
0.8 |
GO:0010873 |
positive regulation of cholesterol esterification(GO:0010873) |
| 0.3 |
0.5 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.3 |
1.1 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.3 |
1.1 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.3 |
0.3 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) |
| 0.3 |
0.5 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.3 |
0.8 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.3 |
12.8 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.3 |
0.3 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.3 |
0.3 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.3 |
0.8 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.3 |
0.8 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.3 |
0.3 |
GO:0042637 |
catagen(GO:0042637) |
| 0.3 |
0.3 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.3 |
0.5 |
GO:2000157 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.3 |
0.3 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.3 |
2.6 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.3 |
5.2 |
GO:0009311 |
oligosaccharide metabolic process(GO:0009311) |
| 0.3 |
0.5 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.3 |
0.3 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.3 |
2.3 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.3 |
0.8 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.3 |
3.1 |
GO:0097066 |
response to thyroid hormone(GO:0097066) |
| 0.3 |
0.5 |
GO:1904478 |
regulation of intestinal absorption(GO:1904478) |
| 0.3 |
0.3 |
GO:1905214 |
regulation of RNA binding(GO:1905214) |
| 0.3 |
1.5 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.3 |
2.8 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.3 |
2.8 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.3 |
0.3 |
GO:0009415 |
response to water(GO:0009415) response to hydrostatic pressure(GO:0051599) |
| 0.3 |
1.0 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.3 |
1.0 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.2 |
0.2 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.2 |
0.2 |
GO:0051953 |
negative regulation of amine transport(GO:0051953) |
| 0.2 |
1.0 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.2 |
4.4 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.2 |
1.2 |
GO:0034390 |
smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.2 |
0.7 |
GO:0036481 |
intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.2 |
1.7 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.2 |
0.7 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.2 |
0.5 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.2 |
4.5 |
GO:0048741 |
skeletal muscle fiber development(GO:0048741) |
| 0.2 |
0.7 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.2 |
4.0 |
GO:0043039 |
tRNA aminoacylation for protein translation(GO:0006418) tRNA aminoacylation(GO:0043039) |
| 0.2 |
0.5 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.2 |
0.9 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.2 |
0.2 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.2 |
0.2 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.2 |
0.7 |
GO:0003418 |
growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.2 |
1.2 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.2 |
0.9 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.2 |
0.9 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.2 |
3.5 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
| 0.2 |
1.1 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.2 |
2.3 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.2 |
2.5 |
GO:0031274 |
regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 |
0.9 |
GO:1902931 |
negative regulation of alcohol biosynthetic process(GO:1902931) |
| 0.2 |
0.4 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.2 |
0.7 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
| 0.2 |
0.7 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.2 |
0.9 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.2 |
0.9 |
GO:0018201 |
peptidyl-glycine modification(GO:0018201) |
| 0.2 |
0.7 |
GO:0071025 |
RNA surveillance(GO:0071025) |
| 0.2 |
0.2 |
GO:0099623 |
regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
| 0.2 |
0.4 |
GO:0035094 |
response to nicotine(GO:0035094) |
| 0.2 |
1.3 |
GO:0051958 |
methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.2 |
0.7 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.2 |
2.4 |
GO:0086036 |
regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 0.2 |
1.1 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.2 |
0.4 |
GO:0051969 |
regulation of transmission of nerve impulse(GO:0051969) |
| 0.2 |
3.9 |
GO:0045471 |
response to ethanol(GO:0045471) |
| 0.2 |
0.4 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.2 |
1.1 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.2 |
0.6 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.2 |
0.8 |
GO:0033561 |
regulation of water loss via skin(GO:0033561) |
| 0.2 |
0.8 |
GO:0042745 |
circadian sleep/wake cycle(GO:0042745) |
| 0.2 |
2.7 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.2 |
0.4 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.2 |
0.6 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.2 |
0.2 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.2 |
0.4 |
GO:0035878 |
nail development(GO:0035878) |
| 0.2 |
0.6 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.2 |
0.6 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.2 |
1.2 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.2 |
0.8 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.2 |
3.2 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.2 |
1.2 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.2 |
1.2 |
GO:0015865 |
purine nucleotide transport(GO:0015865) |
| 0.2 |
0.2 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.2 |
0.2 |
GO:0044849 |
estrous cycle(GO:0044849) |
| 0.2 |
0.2 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.2 |
1.6 |
GO:0043173 |
nucleotide salvage(GO:0043173) |
| 0.2 |
1.6 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 |
3.2 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.2 |
1.8 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.2 |
1.0 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.2 |
0.4 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.2 |
0.4 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.2 |
0.4 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.2 |
0.4 |
GO:0033572 |
transferrin transport(GO:0033572) |
| 0.2 |
0.6 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.2 |
0.4 |
GO:0044336 |
canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.2 |
0.6 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.2 |
0.6 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.2 |
0.6 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.2 |
0.7 |
GO:0090282 |
positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
| 0.2 |
0.4 |
GO:0090646 |
mitochondrial RNA 3'-end processing(GO:0000965) mitochondrial tRNA processing(GO:0090646) |
| 0.2 |
0.9 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.2 |
0.9 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.2 |
0.6 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.2 |
0.2 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 0.2 |
0.2 |
GO:0072488 |
ammonium transmembrane transport(GO:0072488) |
| 0.2 |
1.1 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.2 |
0.2 |
GO:0009110 |
vitamin biosynthetic process(GO:0009110) |
| 0.2 |
0.4 |
GO:0014733 |
regulation of skeletal muscle adaptation(GO:0014733) |
| 0.2 |
0.7 |
GO:1990022 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.2 |
7.4 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.2 |
0.9 |
GO:0015842 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.2 |
0.7 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.2 |
0.2 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.2 |
4.4 |
GO:2000649 |
regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.2 |
0.7 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.2 |
0.5 |
GO:0021825 |
substrate-dependent cerebral cortex tangential migration(GO:0021825) |
| 0.2 |
0.3 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.2 |
0.7 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.2 |
0.3 |
GO:0016074 |
snoRNA metabolic process(GO:0016074) |
| 0.2 |
0.3 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 |
0.7 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.2 |
1.7 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.2 |
0.8 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.2 |
1.2 |
GO:0015879 |
carnitine transport(GO:0015879) |
| 0.2 |
12.0 |
GO:0035308 |
negative regulation of protein dephosphorylation(GO:0035308) |
| 0.2 |
0.7 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.2 |
0.3 |
GO:1902527 |
positive regulation of protein monoubiquitination(GO:1902527) |
| 0.2 |
0.3 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.2 |
1.1 |
GO:0048505 |
regulation of timing of cell differentiation(GO:0048505) |
| 0.2 |
0.2 |
GO:0006818 |
hydrogen transport(GO:0006818) |
| 0.2 |
0.5 |
GO:0098974 |
postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.2 |
1.9 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.2 |
0.5 |
GO:0034116 |
positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.2 |
1.7 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.2 |
2.5 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.2 |
0.3 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.2 |
0.2 |
GO:0070343 |
white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 0.2 |
0.2 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.2 |
0.3 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.2 |
0.3 |
GO:0046104 |
thymidine metabolic process(GO:0046104) |
| 0.2 |
2.0 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.1 |
0.7 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.1 |
1.0 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 |
0.4 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 |
0.9 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.1 |
0.1 |
GO:0046984 |
regulation of hemoglobin biosynthetic process(GO:0046984) |
| 0.1 |
1.3 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.1 |
0.6 |
GO:0034312 |
diol biosynthetic process(GO:0034312) |
| 0.1 |
0.3 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 |
0.1 |
GO:1900120 |
regulation of receptor binding(GO:1900120) |
| 0.1 |
0.1 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.1 |
6.2 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
| 0.1 |
0.1 |
GO:0080111 |
DNA demethylation(GO:0080111) |
| 0.1 |
0.9 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.3 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
3.1 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.1 |
0.3 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.1 |
1.6 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
1.1 |
GO:0003254 |
regulation of membrane depolarization(GO:0003254) |
| 0.1 |
2.4 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.1 |
2.1 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.1 |
0.5 |
GO:0042711 |
maternal behavior(GO:0042711) |
| 0.1 |
0.1 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.1 |
0.1 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.1 |
0.1 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.1 |
0.1 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.1 |
1.2 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.1 |
0.4 |
GO:0090195 |
chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
| 0.1 |
0.1 |
GO:2001170 |
negative regulation of cell proliferation involved in kidney development(GO:1901723) negative regulation of cellular respiration(GO:1901856) negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.1 |
0.4 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.1 |
0.4 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
| 0.1 |
1.7 |
GO:0071548 |
response to dexamethasone(GO:0071548) |
| 0.1 |
0.3 |
GO:0006409 |
tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 |
0.3 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.1 |
2.0 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.1 |
0.9 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.1 |
3.5 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.1 |
0.3 |
GO:0048631 |
skeletal muscle tissue growth(GO:0048630) regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.1 |
0.3 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.1 |
0.6 |
GO:0032402 |
establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) |
| 0.1 |
2.2 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.1 |
0.6 |
GO:0031034 |
myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 |
0.4 |
GO:0006001 |
fructose catabolic process(GO:0006001) response to sucrose(GO:0009744) response to disaccharide(GO:0034285) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.1 |
0.4 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 |
0.1 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.1 |
0.1 |
GO:0032075 |
positive regulation of nuclease activity(GO:0032075) |
| 0.1 |
0.6 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.1 |
0.1 |
GO:0060295 |
regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.1 |
0.1 |
GO:0034969 |
histone arginine methylation(GO:0034969) |
| 0.1 |
0.5 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 |
4.0 |
GO:0008637 |
apoptotic mitochondrial changes(GO:0008637) |
| 0.1 |
0.3 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
0.3 |
GO:0019935 |
cyclic-nucleotide-mediated signaling(GO:0019935) |
| 0.1 |
0.3 |
GO:0071398 |
cellular response to fatty acid(GO:0071398) |
| 0.1 |
0.6 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.1 |
0.1 |
GO:0048208 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.1 |
0.2 |
GO:0046098 |
guanine metabolic process(GO:0046098) |
| 0.1 |
0.6 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.1 |
0.8 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.1 |
0.1 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.1 |
0.2 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) |
| 0.1 |
0.1 |
GO:0072498 |
embryonic skeletal joint development(GO:0072498) |
| 0.1 |
0.1 |
GO:1901387 |
positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.1 |
0.2 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.1 |
0.1 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.1 |
1.7 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.1 |
0.4 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.1 |
1.3 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.1 |
0.1 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.1 |
0.3 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.1 |
0.1 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.1 |
0.7 |
GO:0045686 |
negative regulation of glial cell differentiation(GO:0045686) |
| 0.1 |
0.3 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.1 |
0.5 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.1 |
1.0 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.1 |
0.2 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.1 |
0.5 |
GO:0021535 |
cell migration in hindbrain(GO:0021535) |
| 0.1 |
0.9 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
0.7 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.1 |
1.1 |
GO:0003073 |
regulation of systemic arterial blood pressure(GO:0003073) |
| 0.1 |
0.2 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 |
0.2 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.1 |
0.3 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.1 |
0.7 |
GO:0048678 |
response to axon injury(GO:0048678) |
| 0.1 |
0.2 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.1 |
0.9 |
GO:0051966 |
regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.1 |
0.2 |
GO:0018377 |
N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
| 0.1 |
0.2 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 |
0.2 |
GO:0042401 |
amine biosynthetic process(GO:0009309) cellular biogenic amine biosynthetic process(GO:0042401) |
| 0.1 |
1.8 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
0.6 |
GO:0043113 |
receptor clustering(GO:0043113) |
| 0.1 |
0.1 |
GO:0021882 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
| 0.1 |
0.5 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.1 |
0.3 |
GO:0060312 |
regulation of blood vessel remodeling(GO:0060312) |
| 0.1 |
0.5 |
GO:0097576 |
vacuole fusion(GO:0097576) |
| 0.1 |
0.3 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.1 |
0.2 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 0.1 |
0.1 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.1 |
0.6 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
0.2 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.1 |
0.2 |
GO:0045010 |
actin nucleation(GO:0045010) |
| 0.1 |
0.4 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.1 |
0.3 |
GO:0042795 |
snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 |
0.4 |
GO:0032438 |
melanosome organization(GO:0032438) |
| 0.1 |
0.4 |
GO:0001941 |
postsynaptic membrane organization(GO:0001941) |
| 0.1 |
0.1 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.1 |
0.2 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.1 |
0.4 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
| 0.1 |
0.3 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 |
0.1 |
GO:0072174 |
astrocyte fate commitment(GO:0060018) renal vesicle induction(GO:0072034) metanephric tubule formation(GO:0072174) ureter morphogenesis(GO:0072197) metanephric nephron tubule formation(GO:0072289) |
| 0.1 |
0.2 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 |
0.6 |
GO:0016079 |
synaptic vesicle exocytosis(GO:0016079) |
| 0.1 |
0.2 |
GO:1902235 |
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
| 0.1 |
0.9 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.1 |
0.2 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.1 |
0.1 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.1 |
0.4 |
GO:2000249 |
regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.1 |
2.8 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.1 |
0.7 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 |
0.9 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.1 |
0.1 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.1 |
0.1 |
GO:0009186 |
deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
| 0.1 |
0.1 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.1 |
0.8 |
GO:0045744 |
negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.1 |
0.1 |
GO:0010566 |
regulation of ketone biosynthetic process(GO:0010566) |
| 0.1 |
0.1 |
GO:2000659 |
regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.1 |
0.3 |
GO:0006616 |
SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.1 |
0.1 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.1 |
0.2 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.1 |
0.1 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.1 |
0.9 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 |
0.2 |
GO:0086001 |
cardiac muscle cell action potential(GO:0086001) |
| 0.1 |
0.1 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.0 |
0.0 |
GO:0070460 |
thyroid-stimulating hormone secretion(GO:0070460) |
| 0.0 |
0.4 |
GO:0044406 |
adhesion of symbiont to host(GO:0044406) |
| 0.0 |
1.7 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.0 |
0.0 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.0 |
0.0 |
GO:0033089 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.0 |
0.2 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.2 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.0 |
0.1 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.0 |
3.0 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) |
| 0.0 |
0.4 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 |
0.2 |
GO:0014010 |
Schwann cell proliferation(GO:0014010) |
| 0.0 |
0.1 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.0 |
0.6 |
GO:2000181 |
negative regulation of blood vessel morphogenesis(GO:2000181) |
| 0.0 |
0.0 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.0 |
0.2 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.0 |
0.1 |
GO:0002946 |
tRNA C5-cytosine methylation(GO:0002946) |
| 0.0 |
0.4 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
0.2 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.0 |
0.1 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.0 |
0.3 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.3 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 |
0.1 |
GO:0071806 |
intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
| 0.0 |
0.1 |
GO:0035511 |
oxidative DNA demethylation(GO:0035511) |
| 0.0 |
0.2 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.0 |
0.0 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.0 |
0.0 |
GO:0045606 |
epidermal cell fate specification(GO:0009957) positive regulation of epidermal cell differentiation(GO:0045606) |
| 0.0 |
0.1 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.0 |
0.1 |
GO:0042993 |
positive regulation of transcription factor import into nucleus(GO:0042993) |
| 0.0 |
0.1 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 |
0.1 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.0 |
0.5 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 |
0.1 |
GO:0006144 |
purine nucleobase metabolic process(GO:0006144) |
| 0.0 |
0.1 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.0 |
0.1 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 |
0.0 |
GO:0060278 |
regulation of ovulation(GO:0060278) |
| 0.0 |
1.2 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.0 |
0.2 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.0 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.0 |
0.1 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.0 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.0 |
0.2 |
GO:0010862 |
positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.0 |
0.1 |
GO:0009098 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.0 |
0.1 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.0 |
0.1 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
0.0 |
GO:2000193 |
positive regulation of fatty acid transport(GO:2000193) |
| 0.0 |
0.4 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 |
0.1 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.0 |
0.0 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.0 |
0.1 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.0 |
0.1 |
GO:0052695 |
cellular glucuronidation(GO:0052695) |
| 0.0 |
0.0 |
GO:0002691 |
regulation of cellular extravasation(GO:0002691) |
| 0.0 |
0.1 |
GO:0097581 |
lamellipodium organization(GO:0097581) |
| 0.0 |
0.0 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.0 |
0.1 |
GO:0045103 |
intermediate filament-based process(GO:0045103) |
| 0.0 |
0.0 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
